219 related articles for article (PubMed ID: 16537707)
1. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
4. Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas?
Hartman TJ; Yu B; Albert PS; Slattery ML; Paskett E; Kikendall JW; Iber F; Brewer BK; Schatzkin A; Lanza E
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2359-65. PubMed ID: 16214917
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
[TBL] [Abstract][Full Text] [Related]
6. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
7. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
[TBL] [Abstract][Full Text] [Related]
9. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
11. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
12. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
15. Relationship of visceral adipose tissue to recurrence of adenomatous polyps.
Sass DA; Schoen RE; Weissfeld JL; Weissfeld L; Thaete FL; Kuller LH; McAdams M; Lanza E; Schatzkin A
Am J Gastroenterol; 2004 Apr; 99(4):687-93. PubMed ID: 15089903
[TBL] [Abstract][Full Text] [Related]
16. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.
Murphy G; Sansbury LB; Cross AJ; Stolzenberg-Solomon R; Laiyemo A; Albert PS; Wang Z; Schatzkin A; Lehman T; Kalidindi A; Modali R; Lanza E
Cancer Causes Control; 2008 Sep; 19(7):751-8. PubMed ID: 18322814
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.
Berndt SI; Huang WY; Chatterjee N; Yeager M; Welch R; Chanock SJ; Weissfeld JL; Schoen RE; Hayes RB
Carcinogenesis; 2007 Sep; 28(9):1965-70. PubMed ID: 17615257
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
19. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?
Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Wargovich M; Coker A; Hebert JR
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):631-7. PubMed ID: 12869402
[TBL] [Abstract][Full Text] [Related]
20. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
Alberts DS; MartÃnez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
